Guliz Ozgun
Clinical trials sponsored by Guliz Ozgun, explained in plain language.
-
Morning vs afternoon: can timing boost kidney cancer treatment?
Disease control Not yet recruitingThis study looks at whether getting standard immunotherapy drugs (nivolumab and ipilimumab) in the morning or afternoon makes a difference for people with advanced kidney cancer. About 142 adults will be randomly assigned to morning or afternoon infusions. Researchers will track …
Phase: PHASE3 • Sponsor: Guliz Ozgun • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Morning or afternoon? new study tests best time for bladder cancer drugs
Symptom relief Not yet recruitingThis study looks at whether giving standard bladder cancer drugs in the morning or afternoon changes how well they work and how many side effects they cause. About 224 adults with advanced bladder cancer will be randomly assigned to receive their treatment either before 11:30 a.m…
Phase: PHASE3 • Sponsor: Guliz Ozgun • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC